Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Prognostic Value of Multiple Manual Segmentation Methods for Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
Authors:ID Doma, Andrej (Author)
ID Studen, Andrej (Author)
ID Jezeršek Novaković, Barbara (Author)
Files:URL URL - Source URL, visit https://www.mdpi.com/1718-7729/32/6/356/pdf
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Abstract: Quantitative 18F-FDG PET/CT-derived metabolic metrics are strongly associated with patient outcomes in diffuse large B-cell lymphoma (DLBCL), but the lack of consensus on optimal segmentation thresholds limits standardization. This study evaluated the prognostic value of various metabolic tumor volume (MTV) segmentation approaches in 140 stage II–IV DLBCL patients treated with standard immunochemotherapy. MTV was derived using fixed SUV (≥2.5, ≥4.0), relative (>41% SUVmax), and adaptive (liver-tobackground) thresholds. Baseline MTV metrics significantly correlated with 3-year overall survival (OS3) in univariate analysis in overall cohort, with MTV41 showing the strongest association (HR: 1.27; p = 0.003). MTV25 and MTV41 remained significant in the stage 4 patient subgroup. However, in multivariate analysis, no MTV metric independently predicted OS3 when adjusted for the International Prognostic Index (IPI), which remained the dominant predictor (HR: 1.95; p < 0.0001). ROC analysis confirmed superior AUC for IPI (0.76) over PET-based metrics (0.64–0.69). Predictive models integrating IPI with PET metrics were robust but failed to improve prognostic accuracy beyond IPI alone. Although PET-derived MTV metrics provide prognostic value in univariate analysis, threshold selection has minimal impact, and their added value is limited when combined with IPI, reinforcing its role as the most reliable survival predictor in DLBCL.
Keywords:diffuse large B-cell lymphoma, 18F-FDG, overall survival, PET/CT
Publication status:Published
Publication version:Version of Record
Submitted for review:18.02.2025
Article acceptance date:16.06.2025
Publication date:16.06.2025
Place of publishing:Basel
Publisher:MDPI, Basel, Switzerland
Year of publishing:2025
Number of pages:str. 356-1-356-17
Numbering:Vol. 32
Source:Basel, Switzerland
PID:20.500.12556/DiRROS-24002 New window
UDC:616.1
ISSN on article:1718-7729
DOI:10.3390/curroncol32060356 New window
COBISS.SI-ID:240809731 New window
Copyright:by Authors
Note:Nasl. z nasl. zaslona; Opis vira z dne 30. 6. 2025;
Publication date in DiRROS:21.11.2025
Views:131
Downloads:36
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Current oncology
Publisher:Multimed
ISSN:1718-7729
COBISS.SI-ID:523618841 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0321-2020
Name:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri različnih vrstah raka

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:difuzni velikocelični B-limfom, 18F-FDG, PET/CT, celokupno preživetje, PET/CT


Back